tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

CELC Stock Latest News

Celcuity doses first patient in VIKTORIA-2 trial
The FlyCelcuity doses first patient in VIKTORIA-2 trial
1d ago
CELC
Celcuity announces issuance of new patent for gedatolisib
PremiumThe Fly
Celcuity announces issuance of new patent for gedatolisib
12d ago
CELC
Promising Clinical Trial Results and Favorable Safety Profile Drive Buy Rating for Celcuity’s Gedatolisib
PremiumRatings
Promising Clinical Trial Results and Favorable Safety Profile Drive Buy Rating for Celcuity’s Gedatolisib
24d ago
CELC
Celcuity resumed with a Buy at Stifel
PremiumThe Fly
Celcuity resumed with a Buy at Stifel
25d ago
CELC
Promising Preliminary Data and Positive Outlook for Celcuity’s Gedatolisib in Cancer Trials
PremiumRatings
Promising Preliminary Data and Positive Outlook for Celcuity’s Gedatolisib in Cancer Trials
25d ago
CELC
Celcuity Announces Promising Phase 1 Gedatolisib Results
PremiumCompany AnnouncementsCelcuity Announces Promising Phase 1 Gedatolisib Results
25d ago
8K
CELC
Celcuity reports clinical data from two early phase studies of gedatolisib
Premium
The Fly
Celcuity reports clinical data from two early phase studies of gedatolisib
26d ago
CELC
Celcuity’s Promising Clinical Trials and Strong Financial Position Justify Buy Rating
Premium
Ratings
Celcuity’s Promising Clinical Trials and Strong Financial Position Justify Buy Rating
2M ago
CELC
Celcuity Approves Stock Plan Amendment at Annual Meeting
PremiumCompany Announcements
Celcuity Approves Stock Plan Amendment at Annual Meeting
2M ago
8K
CELC
Celcuity Inc. Earnings Call: Balancing Progress and Challenges
PremiumCompany Announcements
Celcuity Inc. Earnings Call: Balancing Progress and Challenges
2M ago
CELC
Celcuity’s Promising Phase 3 Trial and Strong Market Position: A Buy Recommendation
PremiumRatings
Celcuity’s Promising Phase 3 Trial and Strong Market Position: A Buy Recommendation
2M ago
CELC
Celcuity Inc. Reports Q1 2025 Financial Results
PremiumCompany Announcements
Celcuity Inc. Reports Q1 2025 Financial Results
2M ago
CELC
Celcuity’s Gedatolisib Phase III Trial and Market Potential Drive Buy Rating
PremiumRatingsCelcuity’s Gedatolisib Phase III Trial and Market Potential Drive Buy Rating
2M ago
CELC
Celcuity’s Strong Position and FDA Breakthrough Designation Drive Buy Rating
Premium
Ratings
Celcuity’s Strong Position and FDA Breakthrough Designation Drive Buy Rating
4M ago
CELC
Celcuity’s Strategic Advances and Clinical Trial Progress Bolster Buy Rating
Premium
Ratings
Celcuity’s Strategic Advances and Clinical Trial Progress Bolster Buy Rating
4M ago
CELC
Celcuity Inc. Earnings Call Highlights Progress and Challenges
PremiumCompany Announcements
Celcuity Inc. Earnings Call Highlights Progress and Challenges
4M ago
CELC
Celcuity Stock (CELC) Dips Despite Promising Cancer Treatment in Pipeline
PremiumMarket News
Celcuity Stock (CELC) Dips Despite Promising Cancer Treatment in Pipeline
4M ago
CELC
Promising Developments in Celcuity’s Clinical Trials Drive Buy Rating
PremiumRatings
Promising Developments in Celcuity’s Clinical Trials Drive Buy Rating
4M ago
CELC
Celcuity’s Promising Clinical Trials and Strategic Plans Drive Buy Rating
PremiumRatings
Celcuity’s Promising Clinical Trials and Strategic Plans Drive Buy Rating
4M ago
CELC
Celcuity’s Promising Future: Buy Rating Backed by Strong Clinical Prospects and Financial Stability
PremiumRatingsCelcuity’s Promising Future: Buy Rating Backed by Strong Clinical Prospects and Financial Stability
4M ago
CELC
Celcuity Inc. Reports 2024 Financial Results and Clinical Updates
Premium
Company Announcements
Celcuity Inc. Reports 2024 Financial Results and Clinical Updates
4M ago
CELC
Celcuity Inc. (CELC) Q4 Earnings Cheat Sheet
Premium
Pre-Earnings
Celcuity Inc. (CELC) Q4 Earnings Cheat Sheet
4M ago
CELC

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >